FIELD: chemistry.
SUBSTANCE: present invention relates to novel biaryl carboxyaryl amide derivatives of general formula 
, where: A is N; Z is a phenyl ring substituted with a group R selected from a halogen atom. The invention also relates to use of the compound of formula (I) and to a pharmaceutical composition based on the compound of formula (I).
EFFECT: novel biaryl carboxyaryl amide derivatives, which are useful as type 1 vanilloid receptor modulators, are obtained.
9 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IONONE-BASED VANILLOID VRI RECEPTOR ANTAGONISTS | 2007 |
|
RU2447064C2 |
| TRPVI AGONISTS, PREPARATIONS CONTAINING SAID AGONISTS AND USE THEREOF | 2005 |
|
RU2379282C2 |
| ADENOSINE A3-RECEPTOR MODULATORS | 1999 |
|
RU2250904C2 |
| QUINAZOLINE DERIVATIVES EFFECTIVE AS VANILOID ANTAGONISTS | 2005 |
|
RU2396261C2 |
| ANTAGONISTS OF TRPV1, CONTAINING DIHYDROXY GROUP AS SUBSTITUTE, AND THEIR USE | 2012 |
|
RU2621708C2 |
| TETRASUBSTITUTED IMIDAZOLE DERIVATIVES AS CANNABINOID CB RECEPTOR MODULATORS, HIGHLY SELECTIVE TO SUBRANGE RECEPTORS CB/CB | 2005 |
|
RU2354650C2 |
| PYRAZOLE DERIVATIVES | 2012 |
|
RU2600983C2 |
| RECEPTOR SUBTYPE-SELECTIVE AZABICYCLOALKANE DERIVATIVES | 2008 |
|
RU2417984C1 |
| 3,4-DIHYDROBENZOXAZINE COMPOUNDS AND VANILLOID RECEPTOR SUBTYPE 1 (VR1) INHIBITORS | 2006 |
|
RU2427579C2 |
| 5-SULPHANYL-4H-1,2,4-TRIAZOLE DERIVATIVE AND THEIR USE AS MEDICINAL AGENTS | 2002 |
|
RU2367655C2 |
